Long-term dedication to personalized comprehensive treatment of nasopharyngeal carcinoma and related translational research. Published multiple SCI-indexed papers as first/co-first author in internationally renowned journals such as JAMA Network Open, Clinical Cancer Research, European Journal of Cancer, and Radiotherapy and Oncology. Principal investigator of National Natural Science Foundation Youth Project, Guangdong Natural Science Foundation General Project, and Guangzhou Basic and Applied Basic Research Project. The series of studies has provided new insights into reducing distant metastasis in nasopharyngeal carcinoma through comprehensive treatment. Research findings were highlighted as a featured article in Clinical Cancer Research and adopted by the globally recognized NCCN Guidelines and UpToDate. Abstracts were selected for the 2017 and 2019 American Society of Clinical Oncology (ASCO) Annual Meetings.

Personalized comprehensive treatment of nasopharyngeal carcinoma (including radiotherapy, chemotherapy, immunotherapy, and targeted therapy) and the prevention and management of treatment-related toxicities and side effects.

· 2015–2018: Ph.D. in Oncology, Sun Yat-sen University

· 2012–2015: Master’s in Oncology, Sun Yat-sen University

· 2007–2012: Bachelor’s in clinical medicine, Southern Medical University

1. Liang JL#, Wen YF#, Huang YP#, Guo J, He Y, Xing HW, Guo L*, Mai HQ*,Yang Q*. A prognostic and predictive model based on deep learning to identify optimal candidates for intensity-modulated radiotherapy alone in patients with stage II nasopharyngeal carcinoma: A retrospective multicenter study. Radiother Oncol. 2024 Dec 5:203:110660.

2. Xiang T#, Sun F#, Liu T#, Zhao J, Yang J, Ouyang D, Chen H, Zhu Q, Wang Q, Li Y, He J, Yang C, Yang X, Chen Y, Tang Y, Weng D, Pan Q*,Yang Q*, Xia J*. EBV-associated epithelial cancers cells promote vasculogenic mimicry formation via a secretory cross-talk with the immune microenvironment. Theranostics. 2024 Aug 19;14(13):5123-5140.

3. Guo J#, He Y#, Lin C#, Jiang Q, Xing HW, Zhang YC, Shen GZ, Lin HX*, Guo L*, Yang Q*. Integrating pretreatment MRI-detected nodal features and Epstein-Barr virus DNA to identify optimal candidates for intensity-modulated radiotherapy alone in patients with stage II nasopharyngeal carcinoma. Oral Oncol. 2023 Sep 21:146:106574.

4. Lin C#, Lu N#, Liang JL#, Guo J, Gu LW, Sun R, Guo L*,Yang Q*. Clinical treatment considerations in the intensity-modulated radiotherapy era for parotid lymph node metastasis in patients with nasopharyngeal carcinoma. Radiother Oncol. 2023 Sep:186:109802.

5. Yang Q#, Xia L#, Feng LF#, Gong WJ, Zhu YY, Wang WX, Hua YJ, Li JB*. Multi-trajectories of health-related quality of life and their associated factors in patients with nasopharyngeal carcinoma: A longitudinal study. Radiother Oncol. 2023 Sep:186:109743.

6. Yang Q#, Zou X#, Xie YL#, Lin C#, Ouyang YF, Liu YL, Duan CY, You R, Liu YP, Liu RZ, Huang PY, Guo L, Hua YJ*, Chen MY*. Fosaprepitant Weekly vs Every 3 Weeks for the Prevention of Concurrent Chemoradiotherapy-Induced Nausea and Vomiting: A Pilot Randomized Clinical Trial. JAMA Netw Open. 2023 Jul 3;6(7):e2326127.

7. Yang Q#, Xia L#, Lin M#, Zhang MX#, Duan CY, Liu YP, Xie YL, Wang ZQ, You R, Zou X, Hua YJ, Huang PY, Sun R, Hong MH*, Chen MY. The impact of induction chemotherapy on long-term quality of life in patients with locoregionally advanced nasopharyngeal carcinoma: Outcomes from a randomised phase 3 trial. Oral Oncol. 2021 Oct;121:105494.

8. Yang Q#, Cao SM#, Guo L#, Hua YJ, Huang PY, Zhang XL, Lin M, You R, Zou X, Liu YP, Xie YL, Wang ZQ, Mai HQ, Chen QY, Tang LQ, Mo HY, Cao KJ, Qian CN, Zhao C, Xiang YQ, Zhang XP, Lin ZX, Li WX, Liu Q, Li JB, Ling L, Guo X, Hong MH, Chen MY*. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial. Eur J Cancer. 2019 Sep;119:87-96.

9. Yang Q#, Zhang MX#, Zou X#, Liu YP#, You R, Yu T, Jiang R, Zhang YN, Cao JY, Hong MH, Liu Q, Guo L, Kang T, Zhu X, Chen MY*. A prognostic bio-model based on SQSTM1 and N stage identifies nasopharyngeal carcinoma patients at high risk of metastasis for additional induction chemotherapy. Clin Cancer Res. 2018 Feb 1;24(3):648-658.

10. Yang Q, Zou X, You R, Liu YP, Han Y, Zhang YN, Guo L, Mai HQ, Xie CM, Li L, Hong MH, Chen MY*. Proposal for a new risk classification system for nasopharyngeal carcinoma patients with post-radiation nasopharyngeal necrosis. Oral Oncol. (IF: 5.972) 2017 Apr;67:83-88